Skip to content

Effects of the ultrasound therapy on venous ulcer healing

Effects of ultrasonic waves application on morphometric parameters and metalloproteases gene expression in venous ulcers

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
REBEC
Registry ID
RBR-44xmsx
Enrollment
Unknown
Registered
2012-05-07
Start date
2012-04-07
Completion date
Unknown
Last updated
2025-10-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Venous leg ulcer

Interventions

Twenty volunteers presenting lower limb venous leg ulcer will be divided in two experimental groups. One of the groups (10 patients) will be effectively treated with therapeutic ultrasound in the freq
other
E02.779

Sponsors

Universidade Federal do Rio Grande do Norte
Lead Sponsor
Hospital Universitário Onofre Lopes
Collaborator

Eligibility

Age
18 Years to 90 Years

Inclusion criteria

Inclusion criteria: Unhealed venous ulcer with at least eight weeks of duration Ankle-brachial index equal or higher than 0,8 Without signs of venous ulcer infecction Without previous diagnosis of connective tissue disease that may interfere in the healing process Without contraindication for ultrasound use

Exclusion criteria

Exclusion criteria: Wound infecction Exclusion by patient request

Design outcomes

Primary

MeasureTime frame
Decrease in the area of lower limb venous ulcer measured by an image editing software. The outline corresponding to the edges of lower limb venous ulcer will be digitized and its area will be measured in square centimeters before and after treatment using ultrasonic waves.;Decrease in metalloproteinase (MMP) type 2 and 9 gene expression and/or activity in samples taken from lower limb venous ulcer exsudate. The MMPs expression will be assessed by real-time polymerase chain reaction and MMP and MMPs activity assessed by zymography. The biological sample will be collected before the first and after the last treatment using ultrasonic waves.

Secondary

MeasureTime frame
Pain intensity will be assessed by a visual analog scale. Pain intensity is expected to decrease or maintain pre-treatment levels.;Quality of life will be assessed by the quality of life questionnaires SF-36 and Venous Insufficiency Epidemiological and Economic Study (VEINES). The indexes of quality of life are expect to improve after the treatment.

Countries

Brazil

Contacts

Public ContactFernando Augusto Dias

Universidade Federal do Rio Grande do Norte

faldias@ufrnet.br3342 2024

Outcome results

None listed

Source: REBEC (via WHO ICTRP)